Inventor
David B. Belanger
Inventor
Cambridge, MA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds17%
PatentTitleYear
9,957,254Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators20189,765,067'Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators'20179,227,971'Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors'20168,278,337'Substituted pyridines that are JNK inhibitors'20127,652,020'Compounds for the treatment of inflammatory disorders'20107,576,085'Imidazopyrazines as cyclin dependent kinase inhibitors'20097,563,798'Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors'20097,511,040'Imidazopyrazines as protein kinase inhibitors'20097,060,728'11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders'20066,750,250'11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders'20046,462,061'Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye'20026,348,496'15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders'20026,326,499'Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye'20016,320,062'15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders'20016,255,343'2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2002Patents assigned to ALCON UNIVERSAL LTD (5)· patent assignee history
2001–2002Based in Fort Worth, TX, US· patent location history
2004–2006Patents assigned to ALCON INC (2)· patent assignee history
2004–2016Based in Cambridge, MA, US· patent location history
2009–2010Patents assigned to SCHERING CORP (4)· patent assignee history
2012–2018Patents assigned to BELANGER DAVID B (4)· patent assignee history
2017–2018Patents assigned to ADAMS CHRISTOPHER M (2)· patent assignee history
2017–2018Based in Lexington, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALCON UNIVERSAL LTD | 5 | 2001–2002 |
| BELANGER DAVID Bself | 4 | 2012–2018 |
| SCHERING CORP | 4 | 2009–2010 |
| ADAMS CHRISTOPHER M | 2 | 2017–2018 |
| ALCON INC | 2 | 2004–2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cambridge, Massachusetts, US | 8 | 2004–2016 |
| Fort Worth, Texas, US | 5 | 2001–2002 |
| Lexington, Massachusetts, US | 2 | 2017–2018 |